That modulating these key components of Ito,f might reduce the risk of arrhythmia is also supported by the observation that increasing KChIP2 expression (or inhibiting miR-34) under pathologic conditions prevented reentry arrhythmias [46]. The gene discussed is KCNIP2; the disease is cardiac arrhythmia.